Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

PRAMEF9 TCERG1L ANK3 PRAMEF15 RAPGEF4 MAML1 PEX6 GOLPH3 PRAMEF4 RAD54L2 STAT3 LDB2 NUFIP1 FBXO38 MRTFB LDB1 PKM NCOA7 PRAMEF27 PRAME NOTCH1 MRTFA

8.16e-06116013322GO:0030674
GeneOntologyMolecularFunctionmolecular adaptor activity

PRAMEF9 TCERG1L ANK3 PRAMEF15 RAPGEF4 MAML1 PEX6 GOLPH3 PRAMEF4 RAD54L2 STAT3 TAB3 LDB2 NUFIP1 FBXO38 MRTFB LDB1 TELO2 PKM NCOA7 PRAMEF27 PRAME NOTCH1 MRTFA

9.59e-06135613324GO:0060090
GeneOntologyMolecularFunctionubiquitin-like ligase-substrate adaptor activity

PRAMEF9 PRAMEF15 PRAMEF4 FBXO38 PRAMEF27 PRAME

1.80e-05821336GO:1990756
GeneOntologyMolecularFunctionprotein kinase binding

KIF13B BCL2L11 DSCAM ROR2 MAML1 CASP9 TNIP1 RAD54L2 TESK1 STAT3 RYR2 TELO2 NBEAL2 CDK5RAP1 KCNQ1 TRPV4 TAOK1 MAP4K2

1.99e-0587313318GO:0019901
GeneOntologyMolecularFunctionkinase binding

KIF13B BCL2L11 DSCAM ROR2 MAML1 CASP9 TNIP1 DGKD RAD54L2 TESK1 STAT3 RYR2 TELO2 NBEAL2 CDK5RAP1 KCNQ1 TRPV4 TAOK1 MAP4K2

2.30e-0596913319GO:0019900
GeneOntologyMolecularFunctionenzyme-substrate adaptor activity

PRAMEF9 PRAMEF15 PRAMEF4 FBXO38 PRAMEF27 PRAME

4.17e-05951336GO:0140767
GeneOntologyMolecularFunctionnuclear retinoic acid receptor binding

PRAMEF15 PRAMEF4 PRAMEF27 PRAME

4.93e-04551334GO:0042974
GeneOntologyMolecularFunctionhelicase activity

SMARCA5 ERCC6 ZNFX1 RAD54L2 FBH1 CHTF18

6.70e-041581336GO:0004386
GeneOntologyMolecularFunctionprotein kinase activity

STK36 ROR2 TSSK2 TESK1 CLK3 PKM TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

6.84e-0460013312GO:0004672
GeneOntologyMolecularFunctionprotein serine kinase activity

STK36 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 MAST3 CDK4

7.40e-043631339GO:0106310
GeneOntologyMolecularFunctionATP hydrolysis activity

KIF13B SMARCA5 ERCC6 PEX6 ABCC5 RAD54L2 MDN1 FBH1 ABCC8 CHTF18

7.51e-0444113310GO:0016887
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

STK36 TSSK2 TESK1 CLK3 PKM TAOK1 MAP3K21 MAP4K2 MAST3 CDK4

8.19e-0444613310GO:0004674
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

STK36 ROR2 TSSK2 DGKD TESK1 CLK3 PKM TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

9.14e-0470913313GO:0016773
GeneOntologyMolecularFunctionLIM domain binding

LDB2 LDB1

1.54e-0391332GO:0030274
GeneOntologyMolecularFunctionnuclear receptor binding

PRAMEF15 PRAMEF4 STAT3 NCOA7 PRAMEF27 PRAME

1.60e-031871336GO:0016922
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

SMARCA5 ERCC6 RAD54L2 FBH1 CHTF18

1.62e-031271335GO:0008094
GeneOntologyMolecularFunctionkinase activity

STK36 ROR2 TSSK2 DGKD TESK1 CLK3 PKM TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

1.79e-0376413313GO:0016301
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

SMARCA5 ERCC6 RAD54L2

1.90e-03371333GO:0140658
GeneOntologyMolecularFunctioncomplement component C1q complex binding

C4A C4B

1.91e-03101332GO:0001849
GeneOntologyMolecularFunctionprimary miRNA binding

STAT3 PUS10

1.91e-03101332GO:0070878
GeneOntologyMolecularFunctionribonucleoside triphosphate phosphatase activity

KIF13B SMARCA5 ERCC6 PEX6 ABCC5 RRAD RAD54L2 EFTUD2 MDN1 FBH1 ABCC8 CHTF18 ARL13B

2.02e-0377513313GO:0017111
GeneOntologyCellularComponentCul2-RING ubiquitin ligase complex

PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAME

1.20e-05471335GO:0031462
GeneOntologyCellularComponentB-WICH complex

SMARCA5 ERCC6 SF3B1

1.38e-0581333GO:0110016
GeneOntologyCellularComponentMAML1-RBP-Jkappa- ICN1 complex

MAML1 NOTCH1

1.20e-0431332GO:0002193
GeneOntologyCellularComponentTTT Hsp90 cochaperone complex

TTI2 TELO2

1.20e-0431332GO:0110078
GeneOntologyCellularComponentcullin-RING ubiquitin ligase complex

PRAMEF9 PRAMEF15 PRAMEF4 FBXO38 FBH1 PRAMEF27 PRAME

4.23e-042121337GO:0031461
DomainPRAME_family

PRAMEF25 PRAMEF15 PRAMEF4 PRAMEF27 PRAME

1.63e-07191305IPR026271
DomainLIM-bd/SEUSS

LDB2 LDB1

4.81e-0521302IPR029005
Domain-

SMARCA5 ERCC6 GTPBP6 PEX6 ABCC5 ZNFX1 RRAD RAD54L2 EFTUD2 MDN1 FBH1 ABCC8 CHTF18 ARL13B CARD14

2.17e-04746130153.40.50.300
DomainP-loop_NTPase

KIF13B SMARCA5 ERCC6 GTPBP6 PEX6 ABCC5 ZNFX1 RRAD RAD54L2 EFTUD2 MDN1 FBH1 ABCC8 CHTF18 ARL13B CARD14

2.71e-0484813016IPR027417
DomainPROTEIN_KINASE_ATP

STK36 ROR2 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

3.69e-0445913011PS00107
DomainAnaphylatoxin_comp_syst

C4A C4B

4.74e-0451302IPR018081
DomainAnaphylatoxn_comp_syst_dom

C4A C4B

4.74e-0451302IPR001840
DomainARM-type_fold

STK36 TTI2 PSMD5 ZNFX1 DOCK5 SF3B1 PELP1 TELO2 NBEAL2

6.18e-043391309IPR016024
DomainProt_kinase_dom

STK36 ROR2 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

6.26e-0448913011IPR000719
DomainPROTEIN_KINASE_DOM

STK36 ROR2 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

6.69e-0449313011PS50011
Domain-

ETV6 DGKD PHC2 SAMD3 EPHA10

8.74e-0410613051.10.150.50
DomainANATO

C4A C4B

9.87e-0471302SM00104
DomainSTAT_TF_DNA-bd_sub

STAT3 STAT5A

9.87e-0471302IPR012345
DomainSTAT

STAT3 STAT5A

9.87e-0471302IPR001217
DomainSTAT_int

STAT3 STAT5A

9.87e-0471302SM00964
DomainRPEL

MRTFB MRTFA

9.87e-0471302PS51073
DomainSTAT_TF_DNA-bd

STAT3 STAT5A

9.87e-0471302IPR013801
DomainSTAT_bind

STAT3 STAT5A

9.87e-0471302PF02864
DomainSTAT_int

STAT3 STAT5A

9.87e-0471302PF02865
DomainRPEL

MRTFB MRTFA

9.87e-0471302SM00707
DomainANAPHYLATOXIN_2

C4A C4B

9.87e-0471302PS01178
DomainANAPHYLATOXIN_1

C4A C4B

9.87e-0471302PS01177
Domain-

STAT3 STAT5A

9.87e-04713021.10.532.10
DomainSTAT_alpha

STAT3 STAT5A

9.87e-0471302PF01017
Domain-

STAT3 STAT5A

9.87e-04713021.20.1050.20
DomainSTAT_TF_prot_interaction

STAT3 STAT5A

9.87e-0471302IPR013799
DomainSTAT_TF_coiled-coil

STAT3 STAT5A

9.87e-0471302IPR015988
Domain-

STAT3 STAT5A

9.87e-04713022.60.40.630
DomainANATO

C4A C4B

9.87e-0471302PF01821
DomainRPEL

MRTFB MRTFA

9.87e-0471302PF02755
DomainRPEL_repeat

MRTFB MRTFA

9.87e-0471302IPR004018
DomainAnaphylatoxin/fibulin

C4A C4B

9.87e-0471302IPR000020
DomainSTAT_TF_alpha

STAT3 STAT5A

1.31e-0381302IPR013800
DomainMacrogloblnA2_thiol-ester-bond

C4A C4B

1.31e-0381302IPR019565
DomainThiol-ester_cl

C4A C4B

1.31e-0381302PF10569
DomainMacrogloblnA2_CS

C4A C4B

1.31e-0381302IPR019742
DomainSAM/pointed

ETV6 DGKD PHC2 SAMD3 EPHA10

1.36e-031171305IPR013761
DomainSNF2_N

SMARCA5 ERCC6 RAD54L2

1.41e-03321303IPR000330
DomainSNF2_N

SMARCA5 ERCC6 RAD54L2

1.41e-03321303PF00176
DomainKinase-like_dom

STK36 ROR2 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 EPHA10 MAST3 CDK4

1.44e-0354213011IPR011009
DomainA2M

C4A C4B

2.09e-03101302PF00207
DomainA2M_N_2

C4A C4B

2.09e-03101302IPR011625
DomainA2M_comp

C4A C4B

2.09e-03101302IPR011626
DomainA2M_recep

C4A C4B

2.09e-03101302PF07677
DomainA2M_comp

C4A C4B

2.09e-03101302PF07678
DomainA2M_N

C4A C4B

2.09e-03101302PF01835
DomainA2M_N

C4A C4B

2.09e-03101302IPR002890
DomainA-macroglobulin_rcpt-bd

C4A C4B

2.09e-03101302IPR009048
DomainALPHA_2_MACROGLOBULIN

C4A C4B

2.09e-03101302PS00477
DomainA2M_N_2

C4A C4B

2.09e-03101302PF07703
DomainMacroglobln_a2

C4A C4B

2.09e-03101302IPR001599
DomainARM-like

STK36 TTI2 PSMD5 SF3B1 PELP1 TELO2 NBEAL2

2.85e-032701307IPR011989
DomainSAM

DGKD PHC2 SAMD3 EPHA10

3.33e-03881304SM00454
DomainAAA

PEX6 ABCC5 MDN1 ABCC8 CHTF18

3.36e-031441305SM00382
DomainAAA+_ATPase

PEX6 ABCC5 MDN1 ABCC8 CHTF18

3.36e-031441305IPR003593
DomainSer/Thr_kinase_AS

STK36 TSSK2 CLK3 TAOK1 MAP3K21 MAP4K2 MAST3 CDK4

3.55e-033571308IPR008271
DomainS_TKc

STK36 TSSK2 CLK3 TAOK1 MAP3K21 MAP4K2 MAST3 CDK4

3.67e-033591308SM00220
DomainPROTEIN_KINASE_ST

STK36 TSSK2 CLK3 TAOK1 MAP3K21 MAP4K2 MAST3 CDK4

3.86e-033621308PS00108
DomainSAM_DOMAIN

DGKD PHC2 SAMD3 EPHA10

4.38e-03951304PS50105
DomainSAM

DGKD PHC2 SAMD3 EPHA10

4.71e-03971304IPR001660
DomainProtein_kinase_ATP_BS

STK36 TSSK2 TESK1 CLK3 TAOK1 MAP3K21 MAP4K2 CDK4

5.07e-033791308IPR017441
DomainPkinase

STK36 TSSK2 TESK1 CLK3 TAOK1 MAP4K2 MAST3 CDK4

5.23e-033811308PF00069
DomainC345C

C4A C4B

6.11e-03171302SM00643
DomainTerpenoid_cyclase/PrenylTrfase

C4A C4B

6.84e-03181302IPR008930
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

SMARCA5 ERCC6 ANK3 U2SURP RAPGEF4 CASP9 STAT5A MDN1 NBEAL2 CPSF1 TAOK1 C4A C4B CSPP1

1.07e-084971361436774506
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

HIVEP2 ANK3 GTPBP6 DSCAM RAPGEF4 CEP57L1 ABCC5 PSMD5 ZNFX1 RAD54L2 SLC4A3 STAT3 ZBED5 LDB2 NUFIP1 SF3B1 FBH1 LDB1 ARL13B PKM TAOK1

3.03e-0812851362135914814
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

SMARCA5 EPPK1 ERCC6 WNT10B SF3B1 CLK3 SLIT1 ARL13B PKM RPL3 NOTCH1

1.83e-073581361132460013
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

KIF13B HIVEP2 INPP5E ROR2 TSSK2 ITPRID2 TESK1 STAT3 TAB3 STOX2 MDN1 SBF1 CLK3 NCOA7 MAP3K21 CSPP1

2.85e-078611361636931259
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

STK36 EPPK1 HIVEP2 GTPBP6 BCL2L11 INPP5E MAML1 PEX6 LAMA5 COMTD1 TESK1 PHC2 MDN1 SBF1 NBEAL2 CPSF1 WDR90 NOTCH1

3.39e-0711051361835748872
Pubmed

Functional proteomics mapping of a human signaling pathway.

ERCC6 ANK3 PEX6 LAMA5 TNIP1 RYR2 ZBED5 LDB2 MRTFB SF3B1 LDB1 PELP1 CEP250

6.21e-075911361315231748
Pubmed

The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells.

BCL2L11 STAT3 STAT5A

1.16e-066136323453633
Pubmed

Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.

PRAMEF15 PRAMEF4 PRAMEF27 PRAME

1.55e-0622136431729367
Pubmed

TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.

SMARCA5 U2SURP PSMD5 STAT3 EFTUD2 GMPS SF3B1 CPSF1

2.65e-06220136835785414
Pubmed

MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.

PRAMEF15 PRAMEF4 PRAMEF27 PRAME

2.65e-0625136437451217
Pubmed

Distinct strategies to make nucleosomal DNA accessible.

SMARCA5 ERCC6 SF3B1

3.23e-068136312769854
Pubmed

Nuclear myosin 1 contributes to a chromatin landscape compatible with RNA polymerase II transcription activation.

SMARCA5 ERCC6 SF3B1

3.23e-068136326044184
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

SMARCA5 EFTUD2 GMPS FBXO38 SF3B1 MDN1 PELP1 CEP250

4.18e-06234136836243803
Pubmed

Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.

PRAMEF15 PRAMEF4 PRAMEF27 PRAME

4.26e-0628136425089626
Pubmed

Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression.

SMARCA5 ERCC6 SF3B1

4.83e-069136323555303
Pubmed

The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription.

SMARCA5 ERCC6 SF3B1

4.83e-069136316603771
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

KIF13B ANK3 DSCAM RAPGEF4 RGPD1 ZNFX1 SPECC1L LDB2 EFTUD2 STOX2 SF3B1 MDN1 LDB1 SBF1 PELP1

5.94e-069631361528671696
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

ERCC6 U2SURP DGKD PHC2 EFTUD2 DOCK5 SF3B1 PKM CPSF1 L3HYPDH RPL3

6.00e-065131361125798074
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

EPPK1 RAD54L2 EFTUD2 FBXO38 SF3B1 MDN1 PELP1 PKM NUP160

6.84e-06332136932786267
Pubmed

Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.

U2SURP STAT3 STAT5A GMPS SF3B1 LDB1 C4A

7.36e-06180136730110629
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

STK36 EPPK1 ANK3 ITPRID2 RAD54L2 DOCK5 MRTFB WDR90 NOTCH1 MRTFA

8.00e-064301361035044719
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

SMARCA5 U2SURP EFTUD2 INTS6 SF3B1 FBH1 PELP1 CHTF18 CPSF1

8.27e-06340136924332808
Pubmed

JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

STAT3 STAT5A GH1

9.43e-0611136318499741
Pubmed

Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer.

EPPK1 ITPRID2 EFTUD2 SF3B1 TELO2 PKM RPL3 PRAME

1.01e-05264136832814769
Pubmed

Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.

PRAMEF15 PRAMEF4 PRAMEF27 PRAME

1.07e-0535136419389355
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ANK3 DSCAM MAML1 ABCC5 SPECC1L RYR2 EFTUD2 DOCK5 SF3B1 ARL13B PKM RPL3 NUP160

1.22e-057771361335844135
Pubmed

Protein interactome reveals converging molecular pathways among autism disorders.

LAMA5 TNIP1 DGKD ITPRID2 RAD54L2 SLC22A17 PHC2 SLIT1 PKM RPL3 NOTCH1

1.36e-055601361121653829
Pubmed

Loss of Rearranged L-Myc Fusion (RLF) results in defects in heart development in the mouse.

STAT3 MRTFB NOTCH1 MRTFA

1.49e-0538136427930960
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

1.52e-052136222737222
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

1.52e-052136216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

1.52e-052136215998580
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

1.52e-052136219062096
Pubmed

The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia.

STAT3 STAT5A

1.52e-052136226146825
Pubmed

Regulation of ciliary retrograde protein trafficking by the Joubert syndrome proteins ARL13B and INPP5E.

INPP5E ARL13B

1.52e-052136227927754
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

1.52e-052136219933335
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

1.52e-05213622459207
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

1.52e-052136217645767
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

1.52e-052136212207352
Pubmed

Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer.

STAT3 PKM

1.52e-052136226542452
Pubmed

Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.

STAT3 STAT5A

1.52e-052136215998795
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

1.52e-052136227758680
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

1.52e-052136222387014
Pubmed

STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.

STAT3 STAT5A

1.52e-052136226976954
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

1.52e-052136223749435
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

1.52e-052136223918728
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

1.52e-05213623037333
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

1.52e-052136211726230
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

1.52e-05213624216347
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

1.52e-05213626950384
Pubmed

PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.

STAT3 PKM

1.52e-052136233512635
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

1.52e-05213628660986
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

1.52e-05213628428773
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

1.52e-052136224638111
Pubmed

Nuclear accumulation of pyruvate kinase M2 promotes liver regeneration via activation of signal transducer and activator of transcription 3.

STAT3 PKM

1.52e-052136232198052
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

1.52e-052136221345967
Pubmed

Prognostic correlation of NOTCH1 and SF3B1 mutations with chromosomal abnormalities in chronic lymphocytic leukemia patients.

SF3B1 NOTCH1

1.52e-052136236411516
Pubmed

Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer.

STAT3 CDK4

1.52e-052136232102537
Pubmed

FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.

STAT3 STAT5A

1.52e-052136223243289
Pubmed

Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes.

MAML1 NOTCH1

1.52e-052136220972443
Pubmed

Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.

C4A C4B

1.52e-05213622572548
Pubmed

The complement component C4 of mammals.

C4A C4B

1.52e-05213622302180
Pubmed

PKM2 aggravates palmitate-induced insulin resistance in HepG2 cells via STAT3 pathway.

STAT3 PKM

1.52e-052136228802581
Pubmed

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.

C4A C4B

1.52e-052136222151770
Pubmed

C4d-positive chronic rejection: a frequent entity with a poor outcome.

C4A C4B

1.52e-052136218091514
Pubmed

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

C4A C4B

1.52e-052136229080553
Pubmed

Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.

C4A C4B

1.52e-05213626589636
Pubmed

Myocardin related transcription factors are required for coordinated cell cycle progression.

MRTFB MRTFA

1.52e-052136223656782
Pubmed

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

C4A C4B

1.52e-052136225339671
Pubmed

A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.

C4A C4B

1.52e-052136217728371
Pubmed

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.

STAT3 STAT5A

1.52e-052136233948920
Pubmed

Structure and organization of the C4 genes.

C4A C4B

1.52e-05213626149580
Pubmed

Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.

C4A C4B

1.52e-05213626149581
Pubmed

Reciprocal effects of STAT5 and STAT3 in breast cancer.

STAT3 STAT5A

1.52e-052136219491198
Pubmed

The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

C4A C4B

1.52e-052136212115608
Pubmed

Biochemistry and biology of anaphylatoxins.

C4A C4B

1.52e-05213623542363
Pubmed

C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.

C4A C4B

1.52e-05213622387317
Pubmed

MRTF-A/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants.

MRTFB MRTFA

1.52e-052136220338973
Pubmed

Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.

MRTFB MRTFA

1.52e-052136223853104
Pubmed

Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.

SF3B1 NOTCH1

1.52e-052136228424451
Pubmed

Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.

C4A C4B

1.52e-052136216908004
Pubmed

Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.

C4A C4B

1.52e-05213627365238
Pubmed

Spliced isoforms of LIM-domain-binding protein (CLIM/NLI/Ldb) lacking the LIM-interaction domain.

LDB2 LDB1

1.52e-052136216815859
Pubmed

Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

C4A C4B

1.52e-05213627391573
Pubmed

Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

C4A C4B

1.52e-052136217971360
Pubmed

Clinical features of patients with homozygous complement C4A or C4B deficiency.

C4A C4B

1.52e-052136229928053
Pubmed

The MRTF-A/B function as oncogenes in pancreatic cancer.

MRTFB MRTFA

1.52e-052136226498848
Pubmed

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

C4A C4B

1.52e-052136217971229
Pubmed

Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.

STAT3 NOTCH1

1.52e-052136225544568
Pubmed

Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

MRTFB MRTFA

1.52e-052136212944485
Pubmed

Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.

C4A C4B

1.52e-05213626881182
Pubmed

MRTF-A and STAT3 synergistically promote breast cancer cell migration.

STAT3 MRTFA

1.52e-052136225038455
Pubmed

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.

SF3B1 NOTCH1

1.52e-052136223531595
Pubmed

TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3.

TROAP STAT3

1.52e-052136237298609
Pubmed

Partial C4 deficiency in juvenile idiopathic arthritis patients.

C4A C4B

1.52e-052136217921792
Pubmed

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

C4A C4B

1.52e-052136221880985
Pubmed

Myocardin-related transcription factors are required for skeletal muscle development.

MRTFB MRTFA

1.52e-052136227385017
Pubmed

Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

C4A C4B

1.52e-05213626978711
Pubmed

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

C4A C4B

1.52e-052136235898513
Pubmed

Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

C4A C4B

1.52e-052136228873507
Pubmed

Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.

C4A C4B

1.52e-0521362276882
InteractionFBXO22 interactions

SMARCA5 ERCC6 ANK3 U2SURP RAPGEF4 CASP9 STAT5A EFTUD2 MDN1 NBEAL2 CPSF1 TAOK1 C4A C4B CSPP1

2.38e-0654013115int:FBXO22
InteractionBRCA1 interactions

SMARCA5 ERCC6 HECTD3 TROAP CEP57L1 ETV6 CASP9 ITPRID2 RAD54L2 STAT3 STAT5A NUFIP1 EFTUD2 GMPS FBXO38 SF3B1 MDN1 PKM MAP3K21 RPL3 PRAME NUP160 CDK4

5.29e-06124913123int:BRCA1
InteractionHSP90AA1 interactions

STK36 HECTD3 ROR2 TTI2 TSSK2 TNIP1 TESK1 STAT3 EFTUD2 DOCK5 FBXO38 FBH1 CLK3 CHTF18 CEP250 PKM C4A FGD5 MAP3K21 RPL3 MAP4K2 CDK4

2.07e-05126313122int:HSP90AA1
InteractionAR interactions

SMARCA5 EPPK1 U2SURP MAML1 PSMD5 ITPRID2 RAD54L2 STAT3 EFTUD2 GMPS SF3B1 MDN1 LDB1 PELP1 TELO2 PKM CPSF1 RPL3 PRAME

2.26e-0599213119int:AR
Cytoband1p36.21

PRAMEF25 PRAMEF9 PRAMEF15 CASP9 PRAMEF4

1.30e-066313651p36.21
GeneFamilyPRAME family

PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAME

1.31e-0924876686
GeneFamilyTTT complex

TTI2 TELO2

6.85e-0538721320
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C4A C4B

8.06e-0498721234
GeneFamilySterile alpha motif domain containing

DGKD PHC2 SAMD3 EPHA10

8.57e-0488874760
GeneFamilyATP binding cassette subfamily C

ABCC5 ABCC8

1.72e-0313872807
GeneFamilyAAA ATPases

PEX6 MDN1 CHTF18

2.12e-0353873413
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DSCAM RYR2 LDB2 MRTFB SLIT1 KCNIP4 MAST3

1.63e-06186135784ba666237c18189d7e7556bd92dd953af733c00
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DSCAM RYR2 LDB2 MRTFB SLIT1 KCNIP4 MAST3

2.02e-0619213575c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCellNeuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic

DSCAM RYR2 LDB2 MRTFB SLIT1 KCNIP4 MAST3

2.64e-0620013574409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCell3'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KLK15 KIF13B GJC1 ANKRD36B DLEC1 CARD14

1.02e-051621356075f73ff10e1a7f5695e014e47acc4db513e9cfb
ToppCellControl-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations)

ANK3 LAMA5 ADGRV1 LDB2 STOX2 NCOA7

1.34e-051701356e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ERCC6 BCL2L11 VILL NBEAL2 CHTF18 ARHGAP45

1.58e-051751356a3f8c54c77bce9b035a4835945ab341909be4946
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DSCAM RPP40 RAPGEF4 GJC1 LDB2 FGD5

1.63e-05176135664e426f5e84884ce2c29acf6f4b958962a63927f
ToppCellControl-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations)

RAPGEF4 LDB2 MRTFB ABCC8 KCNIP4 FGD5

2.03e-05183135646be9f96755c7b65aeac061d95d15abeb6466034
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TCERG1L RYR2 LDB2 MRTFB KCNIP4 MAST3

2.36e-05188135650c1b1d690f0e9443082f2adf4f1b8e9ce4cd337
ToppCellCOVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type

RAPGEF4 LDB2 STOX2 MRTFB ABCC8 FGD5

2.36e-051881356d582b76fc2faac526c9bf97503041129e1a6a211
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

RAPGEF4 LDB2 STOX2 NCOA7 KCNIP4 FGD5

2.43e-051891356c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RYR2 LDB2 MRTFB SLIT1 KCNIP4 MAST3

2.43e-051891356a75226616340045b581d08429d2e123e041dee55
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DSCAM RYR2 LDB2 MRTFB KCNIP4 MAST3

2.51e-051901356d594da827e3c16644952b9589cc12b947ce36279
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DSCAM RYR2 LDB2 MRTFB KCNIP4 MAST3

2.51e-05190135649e09cdb843b3d889a06a811aa5affae68b25a75
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KIF13B ANK3 ETV6 NBEAL2 KCNQ1 TRPV4

2.58e-0519113563e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCelldroplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAPGEF4 LAMA5 RYR2 LDB2 MRTFB FGD5

2.74e-05193135654024a373e42e1c0bcc327dc084564b83b63a9d4
ToppCelldroplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAPGEF4 LAMA5 RYR2 LDB2 MRTFB FGD5

2.74e-05193135681d908594d2983ba7e7c1ec25afdde4315d9690e
ToppCellCOVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type

ANK3 ROR2 KCNQ1 KCNIP4 TRPV4 MAP3K21

2.74e-051931356738689d009e4b118d7ce3171a207294b95cbe78b
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HIVEP2 DSCAM RYR2 LDB2 MRTFB KCNIP4

2.90e-0519513562e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C4A RORC C4B WDR90 GMPPA

3.67e-051231355a45d6907c041ad3f3218cd46dccfc25d4bd961cb
Diseasethird ventricle volume measurement

ANK3 LDB2 LDB1

3.10e-05151233EFO_0010335
DiseaseMammary Neoplasms, Experimental

STAT3 STAT5A GH1 PKM RPL3 CDK4

4.88e-051551236C0024668
DiseaseJoubert syndrome 1

INPP5E ARL13B CSPP1

8.90e-05211233C4551568
DiseaseLeukemia, T-Cell

STAT3 NOTCH1

1.71e-0451232C0023492
Diseaseglucose tolerance test

ABCC8 KCNQ1 MAP4K2

1.92e-04271233EFO_0004307
DiseaseFamilial aplasia of the vermis

INPP5E ARL13B CSPP1

2.64e-04301233C0431399
Diseasecreatinine measurement

P4HA2 DSCAM LAMA5 CASP9 GOLPH3 ADGRV1 STAT3 PHC2 KCNQ1 NCOA7 TRPV4 DLEC1 MRTFA

2.70e-0499512313EFO_0004518
DiseaseAnimal Mammary Neoplasms

STAT3 STAT5A PKM RPL3 CDK4

3.30e-041421235C0024667
DiseaseMammary Carcinoma, Animal

STAT3 STAT5A PKM RPL3 CDK4

3.30e-041421235C1257925
Diseaseserum IgG glycosylation measurement

HIVEP2 DSCAM ETV6 RYR2 SBF1 SLIT1 KCNIP4 RPL3 SHISA6

3.56e-045231239EFO_0005193
DiseaseDIABETES MELLITUS, PERMANENT NEONATAL

STAT3 ABCC8

3.57e-0471232C1833104
DiseaseQT interval

DGKD SLC4A3 STAT3 LDB2 DOCK5 ABCC8 KCNQ1 NCOA7 NUP160

4.13e-045341239EFO_0004682
Diseasemenstrual cycle measurement

DOCK5 NOTCH1

4.75e-0481232EFO_0007786
DiseaseCarcinomatosis

STAT3 STAT5A PKM RPL3 CDK4

6.19e-041631235C0205699
DiseaseCarcinoma, Spindle-Cell

STAT3 STAT5A PKM RPL3 CDK4

6.19e-041631235C0205697
DiseaseUndifferentiated carcinoma

STAT3 STAT5A PKM RPL3 CDK4

6.19e-041631235C0205698
DiseaseAnaplastic carcinoma

STAT3 STAT5A PKM RPL3 CDK4

6.19e-041631235C0205696
DiseaseJT interval

DGKD SLC4A3 STAT3 ABCC8 KCNQ1 NCOA7

6.21e-042481236EFO_0007885
DiseaseCarcinoma

STAT3 STAT5A PKM RPL3 CDK4

6.36e-041641235C0007097
Diseasepulse pressure measurement

P4HA2 DSCAM TTI2 LAMA5 SLC22A17 STAT3 LDB2 PHC2 FBXO38 LDB1 SLIT1 FGD5 DLEC1 NUP160 MAP4K2

6.95e-04139212315EFO_0005763
Diseasesexual dimorphism measurement

P4HA2 EPPK1 HIVEP2 INPP5E RGPD1 ETV6 RAD54L2 GH1 PNPLA1 CEP250 SLIT1 CDK5RAP1 KCNQ1

7.31e-04110612313EFO_0021796
Diseaseresponse to radiation, Abnormality of the urinary system

STOX2 ABCC8

7.59e-04101232GO_0009314, HP_0000079
Diseasetype 2 diabetes mellitus (is_implicated_in)

CASP9 RRAD STAT3 ABCC8 CDK4

7.68e-041711235DOID:9352 (is_implicated_in)
Diseasebody weight

HIVEP2 BCL2L11 ROR2 RGPD1 ETV6 ADGRV1 LDB2 PHC2 GH1 ABCC8 SLIT1 KCNQ1 RPL3 NUP160

7.93e-04126112314EFO_0004338
DiseaseLong QT Syndrome

RYR2 KCNQ1

9.25e-04111232C0023976
DiseasePrecursor B-Cell Lymphoblastic Leukemia-Lymphoma

ETV6 STAT3

1.11e-03121232C0023485
Diseasesalicylurate measurement

RYR2 CHTF18

1.30e-03131232EFO_0010532
DiseaseSquamous cell carcinoma of the head and neck

STAT3 NOTCH1 CDK4

1.35e-03521233C1168401
Diseaseankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis

TNIP1 STAT3 PUS10 RORC RPL3 NOTCH1

1.52e-032951236EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Diseasebody surface area

P4HA2 ROR2 RGPD1 ETV6 DOCK5 SLIT1 NCOA7 DLEC1 RPL3

1.53e-036431239EFO_0022196
DiseasePsoriasis

TNIP1 STAT3 CARD14

1.76e-03571233C0033860
DiseasePustulosis of Palms and Soles

TNIP1 STAT3 CARD14

1.76e-03571233C0030246
DiseaseMalignant neoplasm of breast

KLK15 ERCC6 WNT10B TNIP1 RRAD TESK1 STAT3 STAT5A PHKB FGD5 DLEC1 NOTCH1

1.80e-03107412312C0006142
Diseasemyopia (is_implicated_in)

P4HA2 CPSF1

1.99e-03161232DOID:11830 (is_implicated_in)
Diseasecentral nervous system disease (implicated_via_orthology)

SMARCA5 TAOK1

1.99e-03161232DOID:331 (implicated_via_orthology)
DiseaseMalignant Neoplasms

SF3B1 ARHGAP45 NOTCH1 CDK4

2.06e-031281234C0006826
Diseaseheart disease (biomarker_via_orthology)

CASP9 STAT3

2.25e-03171232DOID:114 (biomarker_via_orthology)
DiseaseIntellectual Disability

HIVEP2 INPP5E TTI2 PEX6 SPECC1L ARL13B TAOK1

2.75e-034471237C3714756
Diseaseblood metabolite measurement

GMPS SARDH

2.81e-03191232EFO_0005664
Diseaseulcerative colitis

STAT3 PUS10 SLIT1 RORC RPL3 NOTCH1

2.86e-033351236EFO_0000729
Diseaserenal cell carcinoma (is_implicated_in)

STAT3 C4A C4B

3.03e-03691233DOID:4450 (is_implicated_in)
DiseaseFamilial aplasia of the vermis

INPP5E ARL13B

3.12e-03201232cv:C0431399
DiseaseLupus Erythematosus, Systemic

TNIP1 C4A C4B

3.29e-03711233C0024141
DiseaseNoise-induced hearing loss

KCNQ1 TAOK1

3.77e-03221232C0018781
DiseaseSarcosine measurement

PEX6 SARDH

4.12e-03231232EFO_0021668
Diseasesensory peripheral neuropathy, remission

PRR18 DLEC1

4.12e-03231232EFO_0009785, MONDO_0002321

Protein segments in the cluster

PeptideGeneStartEntry
APRNHEQRLEHIMRR

CHTF18

891

Q8WVB6
RRPHEVFVELNELML

SLC4A3

316

P48751
MERELEALAARLARP

C2orf72

1

A6NCS6
REFHLHLRLPMSVRR

C4B

831

P0C0L5
HLRLPMSVRRFEQLE

C4B

836

P0C0L5
LGEHVVRMLLQREPR

HSD3B7

21

Q9H2F3
MRRLHLIVTRQPNRA

ADGRV1

5386

Q8WXG9
MPVLSARRRELADHA

CLK3

1

P49761
HLRNELRDMRAQLGI

SPECC1L

201

Q69YQ0
EDHPRMVILRLLRYI

BCL2L11

176

O43521
LRMKRNHRVEPLNID

ARL13B

351

Q3SXY8
PEMVHLLVSRRCELN

ANKRD36B

66

Q8N2N9
PSHMRRNIRKLLRED

RAD54L2

106

Q9Y4B4
AKMRARNHLILPERL

ERCC6

1391

Q03468
DIPRRNLLDHLTRMR

INTS6

546

Q9UL03
RIFQEALRLAHMEPV

HDHD3

171

Q9BSH5
RLEALMRWVRHDPQA

KLHL30

196

Q0D2K2
MALLRDVSLQDPRDR

MAP4K2

1

Q12851
HRRSMPVDERDLQAA

RRAD

36

P55042
LRMEEDSIRLPAHLR

ETV6

41

P41212
FALPRHSAVMERLRR

MAML1

11

Q92585
RFLQILRMLHVDRQG

KCNQ1

231

P51787
PHVRLLRQRMDRLDN

MDN1

3291

Q9NU22
NRDITDHMDRLPRDI

NOTCH1

2086

P46531
FMQPLTLRRLEHEKR

ARHGAP45

366

Q92619
IRQHRELIPRSILAM

LDB1

201

Q86U70
VPALLQHDQLIREMR

INPP5E

501

Q9NRR6
EARLQVALAEMPLHR

GTPBP6

216

O43824
TDPRVAERLMQQLHR

MUC20

676

Q8N307
RELVPRSILAMHAQD

LDB2

166

O43679
LNPRAFRMLHVDRRT

CPSF1

1376

Q10570
PAMANHLRLRQVLSR

PNMA6F

376

A0A0J9YX94
RSHRNDIMLLRLVQP

KLK15

101

Q9H2R5
RRRVDHFLCEMPALI

OR2W5P

171

A6NFC9
RVMAVLRHLLLNEDP

PEX6

546

Q13608
AAAHMLRALQPRRTR

C19orf85

26

A0A1B0GUS0
DIFDMARHRLQAPVR

CSPP1

981

Q1MSJ5
KNRRPRHLFLMNDVL

FGD5

1126

Q6ZNL6
LEMATVRHRPEALEL

KCNIP4

61

Q6PIL6
RSRPDRSELVRMHIL

MRTFB

91

Q9ULH7
RDLAPRMLETAHRFA

PNPLA1

36

Q8N8W4
IRAELMNRVRDLRHP

PRAMEF15

436

P0DUQ1
MNRVRDLRHPKRILF

PRAMEF15

441

P0DUQ1
PLEAVRMQHLIAREA

PKM

371

P14618
RHKQPTLLMVRASRR

C6orf223

31

Q8N319
LPGRQELLVAVHMLR

EPHA10

666

Q5JZY3
ERQPGTEMLRADLRH

LAMA5

1666

O15230
RRLHDLVLPLVMGVQ

PELP1

546

Q8IZL8
PSAIEMQLRRVLHDI

ITPRID2

906

P28290
LDARVQAPRVVHMLA

GPR84

341

Q9NQS5
VARMRADENHPQRVL

SBF1

451

O95248
DDPVVARVNRRMQHI

P4HA2

391

O15460
ARNLEHLEMVRVPFL

FBXO38

261

Q6PIJ6
RLHDELFRRILRSPM

ABCC5

946

O15440
RRPLAVRARVIHFME

PUS10

451

Q3MIT2
NRSPRHMIEEIVLVD

GALNT1

141

Q10472
MLEAHRRQRHPFLLL

GMPPA

126

Q96IJ6
RAMERTVENIVLPRH

FBH1

1021

Q8NFZ0
LARLIPRMCHNVNRV

GMPS

546

P49915
REKQRLVRMHAICPR

CARD14

426

Q9BXL6
TAVHIQLIMERLLRR

DOCK5

921

Q9H7D0
RRLEAFEHPNVVRLM

CDK4

61

P11802
LPADLEALQREIRMA

GJC1

331

P36383
SRELFRPHMIEDIQR

CASP9

31

P55211
RSMREHPALRSLRLL

COMTD1

61

Q86VU5
RSVLEHLPMAVQERE

CEP250

1486

Q9BV73
VNDPHRMDRRLLALI

GOLPH3

226

Q9H4A6
AVSHIPVRVADERRM

ANK3

2956

Q12955
TRGPEAELVVMRRLH

MAST3

1241

O60307
LAEMDRQLRRLADTP

DGKD

1076

Q16760
PIRVHNLQMKLRRDD

CEP57L1

441

Q8IYX8
IPRCQERLLRVSQHM

CEP295

1236

Q9C0D2
ERLLRVSQHMLPLQD

CEP295

1241

Q9C0D2
WMNHLRVPQRELDRL

DLEC1

301

Q9Y238
EDPELVRAMFVLLHR

RYR2

2076

Q92736
LRPMLKVSLLNERHR

PRR18

231

Q8N4B5
REFHLHLRLPMSVRR

C4A

831

P0C0L4
HLRLPMSVRRFEQLE

C4A

836

P0C0L4
MHGRPLFLVLIREDN

PHKB

611

Q93100
VRPDDVHMNIRLVEL

RGPD1

151

P0DJD0
MATLRRLREAPRHLL

RPP40

1

O75818
LRMHIDIPRAQLLIE

DSCAM

1656

O60469
RIRPMNRRETDLHTK

KIF13B

11

Q9NQT8
HQRELMLANELRADP

RHOXF1

161

Q8NHV9
RNAILSRAPHMIRDR

RAPGEF4

211

Q8WZA2
GRLDQLLRHVMNPLE

PRAME

311

P78395
PRRTLQEHRLDSNLM

TMEM132E

281

Q6IEE7
QEHRLDSNLMIRLPD

TMEM132E

286

Q6IEE7
QALLLHQRARMERLA

TAB3

516

Q8N5C8
LRILAERNRPHGQML

SLC22A17

256

Q8WUG5
EARLFAMLRHPNIIE

MAP3K21

171

Q5TCX8
MHIEQLARRLPARVQ

NCOA7

786

Q8NI08
RVIAHTQMRLLPLRQ

RPL3

161

P39023
PDHSMRIRIIEFLQA

SAMD3

166

Q8N6K7
QGLIRHFRPELEERM

NDUFV1

436

P49821
VRLHMLLQTAVPARR

NBEAL2

1601

Q6ZNJ1
TQERMSIPEALRRHI

EPPK1

1581

P58107
IRAELMKRVRDLRHP

PRAMEF25

436

A6NGN4
PREMNIHRALADILR

SHISA6

206

Q6ZSJ9
RMLLGRHNLEQDLVR

TAOK1

621

Q7L7X3
HRGLRMLFPEAQRLE

TFB1M

261

Q8WVM0
HLAMDSQRRPLLLQV

TELO2

321

Q9Y4R8
IRAELMNRVRDLRHP

PRAMEF27

436

A3QJZ7
PLREEFRHEAMLRAR

ROR2

516

Q01974
RNPIHAIGLLIREMD

NUP160

666

Q12769
RSRPERSELVRMHIL

MRTFA

31

Q969V6
QHLDHVRRRLMFEPR

L3HYPDH

56

Q96EM0
RNMRRDPLHEELLGQ

SARDH

481

Q9UL12
RNLQREIEIMRGLRH

STK36

46

Q9NRP7
ARHVEELLRRPMDSL

STAT5A

761

P42229
IPTERNLLALIHRMI

U2SURP

421

O15042
LHRSLLNRIILAPMR

ABCC8

1096

Q09428
HLLDQVSRVDPEMRI

CDK5RAP1

356

Q96SZ6
ILLPLEERVTHFRDM

TCERG1L

446

Q5VWI1
PREDGNLMLHLQRLE

TNIP1

151

Q15025
IRAELMNRVRDLRHP

PRAMEF4

436

O60810
MNRVRDLRHPKRILF

PRAMEF4

441

O60810
RRRQGQRDLELPDMH

PHC2

761

Q8IXK0
DCQRMVVRHARRLLP

WDR90

586

Q96KV7
MDRAPQRQHRASREL

RORC

1

P51449
EMLLAPDIRHERNVI

NUFIP1

456

Q9UHK0
ILTHMEPEHRLLLRR

TTI2

346

Q6NXR4
PLLEDALMDRDLVHR

SF3B1

1171

O75533
RRINPDLTVENVMRH

STOX2

316

Q9P2F5
HRPMLEERIVELFRN

STAT3

301

P40763
IRAELMNRVRDLRHP

PRAMEF9

436

P0DUQ2
MNRVRDLRHPKRILF

PRAMEF9

441

P0DUQ2
ADKLHRARRMDLAPQ

TTC41P

1156

Q6P2S7
LEPFVMREVRARLAA

THUMPD2

26

Q9BTF0
LAQRVPLRENREMSH

TROAP

281

Q12815
PLSRLFDNAMLRAHR

GH1

31

P01241
NTLREVQLMNRLRHP

TESK1

96

Q15569
LRREQLMHQAVEDLP

VILL

796

O15195
ELRNKREFRRNLPMH

ZNFX1

696

Q9P2E3
RLDAAPHMRIRLSNI

ZBED5

661

Q49AG3
LLQAMEPVHVARNLR

PSMD5

71

Q16401
SREAPRDIQARMRIH

WNT10B

216

O00744
APHLAREFMIKTRRR

EFTUD2

926

Q15029
VERLHMVLRPFLLRR

SMARCA5

381

O60264
RHLSPRKEAALRREM

HIVEP2

2086

P31629
LERLRLNRNQLHMLP

SLIT1

111

O75093
RMLQPDVSQRLHIDE

TSSK2

251

Q96PF2
RHEMLAVEPINELLR

TRPV4

446

Q9HBA0
INRRLAMEHRACPSR

HECTD3

476

Q5T447